Intarcia Therapeutics appoints Head of Global Medical Affairs, Safety and Operations Intarcia Therapeutics appoints Head of Global Medical Affairs, Safety and Operations John Yee takes the newly created position at the US biopharmaceutical firm Mylan CEO Heather Bresch elected Chair of Generic Pharmaceutical Association Mylan CEO Heather Bresch elected Chair of Generic Pharmaceutical Association She will hold this position for one year Torsten Derr to head Lanxess subsidiary Saltigo Torsten Derr to head Lanxess subsidiary Saltigo Takes over from Wolfgang Schmidt, who is retiring, on 1 April 2016 Patheon appoints Global Business Controller Patheon appoints Global Business Controller Andrew Long will build the firm's financial planning and performance management tools and processes Mike Thompson to become Chief Executive of the Association of the British Pharmaceutical Industry Mike Thompson to become Chief Executive of the Association of the British Pharmaceutical Industry He takes up the position on 1 March and Acting CEO Alison Clough will step down Tocagen appoints John Wood as Vice President, Regulatory Affairs and Quality Assurance Tocagen appoints John Wood as Vice President, Regulatory Affairs and Quality Assurance Wood holds more than 20 years of regulatory affairs experience focusing on drugs for diseases with high unmet need Sygnature Discovery makes two key appointments as expansion continues Sygnature Discovery makes two key appointments as expansion continues Also expands its team of scientists by adding six people to the team Recipharm names 2015 International Environmental Award winner Recipharm names 2015 International Environmental Award winner Jerker Fick takes the award for his research into the effect pharmaceuticals have on the environment Cognition Life Science hires Chuanhai Cao as Chief Scientific Officer Cognition Life Science hires Chuanhai Cao as Chief Scientific Officer Cao is a top researcher at the University of Southern Florida in Tampa Avita makes three key board appointments Avita makes three key board appointments Three are based in the US and three in Australia Clariant welcomes Britta Fuenfstueck as new member of the Executive Committee Clariant welcomes Britta Fuenfstueck as new member of the Executive Committee Former CEO of the Clinical Products Division at Siemens Healthcare joins the firm on 1 April Michael Martino becomes President and Chief Executive of HemaFlo Therapeutics Michael Martino becomes President and Chief Executive of HemaFlo Therapeutics Brings operating expertise to development-stage company focused on developing therapies for diseases caused by poor blood flow Astellas names James Robinson as President, Americas Operations Astellas names James Robinson as President, Americas Operations He takes up the role on 1 April, succeeding Masao Yoshida, who retires in June Sanofi appoints Muzammil Mansuri as Executive Vice President, Strategy & Business Development Sanofi appoints Muzammil Mansuri as Executive Vice President, Strategy & Business Development Also joins the Executive Committee at the French drugmaker New VP of Development and Analytical Services at Catalent New VP of Development and Analytical Services at Catalent Sally Langa joins the US drug delivery technology specialist David Budd to join Epistem as Chief Executive David Budd to join Epistem as Chief Executive He will start his new role by the middle of April